
An amazing moment at Iso as we close our Series C funding round! We founded Iso on the conviction that AI can transform biology into a programmable science. We are clearly seeing this play out internally with our models’ capabilities translating into new potential medicines for patients. This funding will supercharge our efforts, so we can push even deeper into the hard problems of understanding disease biology, engineering the most exquisite molecules possible, and bringing new drugs to patients who need them. Lots more to come!








